郭麾

This profile gathers the share dealings of 郭麾 across 2 companies, led by 派林生物 and 尤夫股份. We count 5 filings; the first trade dates from 25 July 2024 and the latest from 14 January 2025.

The open-market record is one-sided, with 5 purchases worth €17k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2025: 3 purchases and no sales on the market.

A typical purchase (the median) is worth €2,742. Clusters matter here: 3 out of 5 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster. After 5 purchases with a full 90-day history, the hit rate stands at 80% and the median 90-day move at +13.6%. These figures describe past trades and do not predict future prices.

Most recently, on 14 January 2025, the filings show an open-market purchase worth €4,321 in 派林生物. Publication is fast: at least half of the trades appear on SSE / SZSE (CSRC) on the same day. The shorter that gap, the sooner other investors can see what insiders have done. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.